NPCE
Price:
$15.63
Market Cap:
$532.89M
NeuroPace, Inc. is a U.S.-based medical technology firm. It specializes in the creation and distribution of the RNS system, an advanced brain-responsive neuromodulation device designed to manage medically intractable focal epilepsy. This innovative system delivers tailored, real-time therapy directly to the source of seizures. Furthermore, the RNS system continuously records brain activity, providing medical professionals with the capability to monitor patients both on-site and remotely. The company supplies its devices to hospitals for both initial surgical implantations and subsequent replacement procedures. NeuroPace, Inc. was founded in 1997 and maintains its corporate headquarters in Mo...[Read more]
Industry
Medical - Devices
IPO Date
2021-04-22
Stock Exchange
NASDAQ
Ticker
NPCE
According to NeuroPace, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -24.05. This represents a change of -1.66% compared to the average of -24.46 of the last 4 quarters.
The mean historical PE Ratio of NeuroPace, Inc. over the last ten years is -9.96. The current -24.05 PE Ratio has changed 24.05% with respect to the historical average. Over the past ten years (40 quarters), NPCE's PE Ratio was at its highest in in the December 2020 quarter at 891.43. The PE Ratio was at its lowest in in the December 2025 quarter at -47.25.
Average
-9.96
Median
-9.24
Minimum
-23.39
Maximum
-0.78
Discovering the peaks and valleys of NeuroPace, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 940.64%
Maximum Annual PE Ratio = -0.78
Minimum Annual Increase = -83.21%
Minimum Annual PE Ratio = -23.39
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -23.39 | 94.43% |
| 2024 | -12.03 | 48.22% |
| 2023 | -8.12 | 940.64% |
| 2022 | -0.78 | -83.21% |
| 2021 | -4.65 | -59.62% |
| 2020 | -11.50 | 24.42% |
The current PE Ratio of NeuroPace, Inc. (NPCE) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-14.51
5-year avg
-9.79
10-year avg
-9.96
NeuroPace, Inc.’s PE Ratio is greater than Cerus Corporation (-52.63), less than RxSight, Inc. (-4.19), less than CVRx, Inc. (-2.45), less than 908 Devices Inc. (-9.03), less than BrainsWay Ltd. (64.51), less than Senseonics Holdings, Inc. (-3.12), less than Sight Sciences, Inc. (-7.45), less than Delcath Systems, Inc. (708.48), less than Genelux Corporation (-3.37), less than Aldeyra Therapeutics, Inc. (-4.29),
| Company | PE Ratio | Market cap |
|---|---|---|
| -52.63 | $541.00M | |
| -4.19 | $195.81M | |
| -2.45 | $131.35M | |
| -9.03 | $334.65M | |
| 64.51 | $584.03M | |
| -3.12 | $281.69M | |
| -7.45 | $287.28M | |
| 708.48 | $403.56M | |
| -3.37 | $111.53M | |
| -4.29 | $118.23M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NeuroPace, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like NeuroPace, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is NeuroPace, Inc.'s PE Ratio?
How is the PE Ratio calculated for NeuroPace, Inc. (NPCE)?
What is the highest PE Ratio for NeuroPace, Inc. (NPCE)?
What is the 3-year average PE Ratio for NeuroPace, Inc. (NPCE)?
What is the 5-year average PE Ratio for NeuroPace, Inc. (NPCE)?
How does the current PE Ratio for NeuroPace, Inc. (NPCE) compare to its historical average?